Targeting Neutrophils as effector cells in cancer therapy
Hematology, Science
Speaker(s)
Prof., Marjolein van Egmond
The fourth episode of “Immuno Oncology Talks”, Professor Marjolein van Egmond from the Amsterdam University Medical Center, in the Netherlands, will shed light on neutrophils as effector cells in cancer therapy. Professor Marjolein van Egmond specializes in the innate immune system and is focusing on elucidating the therapeutic potential of neutrophils in cancer, with a specific interest in IgA and bispecific antibodies to activate the neutrophils.
For more information please visit:
Sanofi Immuno Oncology Talks website
MAT-BE-2200978 (ver. 1.0) 12 2022
Also interesting...

Hematology, Science
Non-viral RNA treatment approaches in Cancer Immunotherapy

Hematology, Science
Adoptive therapy with engineered T cell receptors

Hematology, Science
Tumor-Infiltrating Lymphocyte Based Adoptive Cellular Therapy

Hematology, NK Cells, Science
NK cell-based cancer immunotherapies

Hematology, Science